Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Symptom improvement | |||||
Systematic review |
People with psoriasis; number of people not reported |
Rate of marked improvement
12 weeks
with PUVA plus calcipotriol with PUVA alone |
RR 1.2 95% CI 0.9 to 1.6 |
Not significant | |
People with psoriasis; number of people not reported |
Rate of marked improvement
at 8 weeks
with UVB plus calcipotriol with UVB alone |
RR 1.0 95% CI 0.8 to 1.1 |
Not significant | ||
RCT |
164 people |
Median number of UVB treatments required to achieve clearance
22 with UVB plus calcipotriol 25 with UVB alone |
RR 3.66 95% CI 2.16 to 6.20 |
Moderate effect size | UVB plus calcipotriol |